Skip to main content
Clinical Trials/NCT00706940
NCT00706940CompletedNot Applicable

Tear Dynamics After Restasis Treatment in Dry Eye Patients Phase II Clinical Trial and Phase IIb 6-month Follow-up After Discontinuation of Study Treatment

University of Miami1 site in 1 country60 target enrollmentStarted: August 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Tear meniscus volume after treatment

Study Overview

Brief Summary

Observe the changes of tear volume in dry eye patients after Restasis treatment of 3 months and during 6-month follow-up after discontinuation of study treatment.

Detailed Description

Using an imaging device name optical coherence tomography to image the tear volume in dry eye patients before and after Restasis treatment.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The participant will be eligible for entry in the study if s/he:
  • Is at least 18 years old and has full legal capacity to volunteer;
  • Has read and signed the IRB Informed Consent Document;
  • Is willing and able to follow participant instructions;
  • Has clear corneas;
  • Has 20/100 uncorrected visual acuity or better;
  • Has dry eye according to the study definition of DES (study subjects);
  • Has not use Restasis within 3 months.

Exclusion Criteria

  • The subjects will ineligible for entry into the study if s/he:
  • Has any systemic disease affecting ocular health except for Sjögren's syndrome;
  • Is using any systemic or topical medications that will affect ocular health except for artificial tears;
  • Has an active ocular disease other than DES, or Sjögren's syndrome
  • Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities;
  • Has limbal or bulbar injection or corneal staining that was clinically significant, which are not due to DES;
  • Has worn rigid gas permeable lenses within 1 year and during the study;
  • Has had surgery or an eye injury within 6 months;
  • Was a soft contact lens wearer within 2 weeks and during the study.

Outcomes

Primary Outcomes

Tear meniscus volume after treatment

Time Frame: 3 months

Significant increase in tear meniscus volume was found in patients after 3 months of treatment.

Increase in tear volume after the 3-month treatment and returned to baseline during 6-month follow-up after discontinuation of study treatment.

Time Frame: 3 months for treatment and follow-up of 6 months after discontinuation of study treatment.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jianhua (Jay) Wang, MD, PhD

Associate Professor

University of Miami

Study Sites (1)

Loading locations...

Similar Trials

Tear Dynamics After Restasis Treatment in... | Clinical Trial